Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-02-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/critical-appraisal-of-bepotastine-in-the-treatment-of-ocular-itching-a-a6345 |